# Establishment of an Early Warning Screening System for Hemophagocytic Lymphohistiocytosis a Multi-center, Prospective Study

> **NCT06614998** · — · RECRUITING · sponsor: **The Affiliated Hospital of Xuzhou Medical University** · enrollment: 80 (estimated)

## Conditions studied

- Hemophagocytic Syndrome

## Interventions

- **DRUG:** Patients diagnosed with HLH-94 should be treated as soon as possible

## Key facts

- **NCT ID:** NCT06614998
- **Lead sponsor:** The Affiliated Hospital of Xuzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-01
- **Primary completion:** 2026-05-01
- **Final completion:** 2026-05-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06614998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06614998, "Establishment of an Early Warning Screening System for Hemophagocytic Lymphohistiocytosis a Multi-center, Prospective Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06614998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*